Prograf (tacrolimus) capsules, USP, 0.5 mg, 100-count bottle, Rx Only, Product of Japan, Distributed by: Astellas Pharma US, Inc., Northbrook, IL 60062, NDC 0469-0607-73.
Published February 5, 2025 · Recall initiated: December 23, 2024
Summary
FDA records drug Class I recall D-0211-2025, published February 5, 2025 and initiated December 23, 2024. Recalling firm: Astellas Pharma US Inc.; Status: Ongoing; Reported quantity: 14,340 100-count bottles; Lot: Lot# 0E3353D, Exp 03/31/2026. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Tablet/Capsule Specifications: Bottles shipped to the USA may contain empty capsules
What to do
Voluntary: Firm initiated · Press Release
Get an email if PROGRAF has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- PROGRAF
- Manufacturer
- Astellas Pharma US Inc.
- Distributor
- Nationwide in the USA
- UPC
- 0304690607731
- Lot
- Lot# 0E3353D, Exp 03/31/2026
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAstagraf XL (tacrolimus extended-release capsules) 0.5 mg, 30-count bottles, RX Only, Product of Japan,February 5, 2025
- FDADuloxetine Delayed-Release Capsules USP, 20 mg, packaged in a) 30 Unit Doses (3x10 blister packs) NDCFebruary 5, 2025
- FDABADGER 50, ADVENTURE SPORT MINERAL SUNSCREEN WITH CLEAR ZINC, (uncoated 25% zinc oxide), 2.4 oz., Tin, W.S.February 5, 2025
- FDAInflectra (infliximab-dyyb), For injection, 100mg per vial, packaged in 10 mL single-dose vial, Rx only, MfdFebruary 5, 2025
- FDASimple Truth Organic, BROCCOLI FLORETS, STEAM IN BAG, 12oz, BEST IF USED BY NOV 08 2024, PRODUCT OF MEXICOFebruary 5, 2025
- FDABaxter Continu-Flo Solution Set with Duo-Vent Spike, REF UC8519January 29, 2025
Questions about this recall
Was Prograf (tacrolimus) capsules, USP, 0.5 mg, 100-count bottle, Rx Only, Product of Japan, Distributed by: Astellas Pharma US, Inc., Northbrook, IL 60062, NDC 0469-0607-73. recalled?
Yes. FDA published recall D-0211-2025 on February 5, 2025. Reported hazard: Failed Tablet/Capsule Specifications: Bottles shipped to the USA may contain empty capsules
What should I do if I have this product?
Voluntary: Firm initiated · Press Release
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: PROGRAF. UPC: 0304690607731.